These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14662210)

  • 21. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
    JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.
    Lambert LJ; Straton JA; Knuiman MW; Bartholomew HC
    J Epidemiol Community Health; 2003 Apr; 57(4):294-300. PubMed ID: 12646547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
    Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
    JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone therapies in women aged 40 and older: prevalence and correlates of use.
    Carney PA; Tosteson AN; Titus-Ernstoff L; Weiss JE; Goodrich ME; Manganiello P; Kasales CJ
    Maturitas; 2006 Jan; 53(1):65-76. PubMed ID: 16325024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen replacement therapy. A survey of older women's attitudes.
    Salamone LM; Pressman AR; Seeley DG; Cauley JA
    Arch Intern Med; 1996 Jun; 156(12):1293-7. PubMed ID: 8651837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and determinants of estrogen replacement therapy in elderly women.
    Cauley JA; Cummings SR; Black DM; Mascioli SR; Seeley DG
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1438-44. PubMed ID: 2240084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of hormone replacement therapy on antithrombin III and protein C levels in menopausal women.
    Lacroix KA; Bean C; Reilly R; Curran-Celentano J
    Clin Lab Sci; 1997; 10(3):145-8. PubMed ID: 10167774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
    Schonberg MA; Davis RB; Wee CC
    Womens Health Issues; 2005; 15(4):187-95. PubMed ID: 16051110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Ross RK; Paganini-Hill A; Wan PC; Pike MC
    J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of dementia in long-term hormone users.
    Petitti DB; Crooks VC; Chiu V; Buckwalter JG; Chui HC
    Am J Epidemiol; 2008 Mar; 167(6):692-700. PubMed ID: 18218608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy.
    Tannen RL; Weiner MG; Xie D; Barnhart K
    Hum Reprod; 2007 Jun; 22(6):1769-77. PubMed ID: 17347166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen plus progestin and risk of venous thrombosis.
    Cushman M; Kuller LH; Prentice R; Rodabough RJ; Psaty BM; Stafford RS; Sidney S; Rosendaal FR;
    JAMA; 2004 Oct; 292(13):1573-80. PubMed ID: 15467059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC; Felson DT; Williams EN; Grady D
    Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women.
    Grodstein F; Stampfer MJ; Falkeborn M; Naessen T; Persson I
    Epidemiology; 1999 Sep; 10(5):476-80. PubMed ID: 10468418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998.
    Ferrara A; Quesenberry CP; Karter AJ; Njoroge CW; Jacobson AS; Selby JV;
    Circulation; 2003 Jan; 107(1):43-8. PubMed ID: 12515741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of oestrogen replacement therapy in South Australia.
    MacLennan AH; MacLennan A; Wilson D
    Maturitas; 1993 May; 16(3):175-83. PubMed ID: 8515717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.